FdaApplication

ANDA 216404

Back to search

Identifiers

Properties

PropertyValue
applicant_nameINGENUS PHARMACEUTICALS LLC
application_typeANDA
approval_date2022-12-02

Products (3)

ProductActive ingredientStrengthDosage form
CARBAMAZEPINECARBAMAZEPINE400MGTABLET, EXTENDED RELEASE;ORAL
CARBAMAZEPINECARBAMAZEPINE200MGTABLET, EXTENDED RELEASE;ORAL
CARBAMAZEPINECARBAMAZEPINE100MGTABLET, EXTENDED RELEASE;ORAL

3 products